Form 4 for SRPT Sarepta Therapeutics, Inc.
Accepted 2025-05-19 00:00:00 ET · period of report 2025-05-16 · accession 0000950170-25-073954 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-05-19 | 2025-05-16 | SRPT | Barry Richard | Dir | M - OptEx | $32.63 | +12.3K | 2.97M | +0.4% | +$403.0K |
| D | 2025-05-19 | 2025-05-16 | SRPT | Barry Richard | Dir | M - OptEx | $0.00 | -12.3K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-05-16 | M | A | 12,350 | $32.63 | 2,966,667 | D | — | — | |
| 2 | Derivative | Stock Option (right to buy) | 2025-05-16 | M | D | 12,350 | $0.00 | 0 | D | $32.63 · 2018-03-10 to 2027-03-10 | 12,350 Common Stock |